| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.16 | 0.2 |